{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T21:35:11Z","timestamp":1789767311935,"version":"4.0.1"},"reference-count":68,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFA1300503"],"award-info":[{"award-number":["2021YFA1300503"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32030064"],"award-info":[{"award-number":["32030064"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32250013"],"award-info":[{"award-number":["32250013"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["XDB38040100"],"award-info":[{"award-number":["XDB38040100"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.omtn.2025.102807","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T06:29:10Z","timestamp":1766125750000},"page":"102807","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Circular RNA encoding relaxin-2 as a potential therapy for liver fibrosis"],"prefix":"10.1016","volume":"37","author":[{"given":"Jiewen","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixing","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6605-3637","authenticated-orcid":false,"given":"Zefeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2025.102807_bib1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omtn.2025.102807_bib2","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1096\/fj.08-120857","article-title":"Relaxin inhibits renal myofibroblast differentiation via RXFP1, the nitric oxide pathway, and Smad2","volume":"23","author":"Mookerjee","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.omtn.2025.102807_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1316","article-title":"Runx2 activates hepatic stellate cells to promote liver fibrosis via transcriptionally regulating Itgav expression","volume":"13","author":"Zhong","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.omtn.2025.102807_bib4","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41577-021-00639-3","article-title":"Immune cell-mediated features of non-alcoholic steatohepatitis","volume":"22","author":"Huby","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.omtn.2025.102807_bib5","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.omtn.2025.102807_bib6","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.cgh.2024.08.020","article-title":"Global Prevalence of Advanced Liver Fibrosis and Cirrhosis in the General Population: A Systematic Review and Meta-analysis","volume":"23","author":"Zamani","year":"2025","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.omtn.2025.102807_bib7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41573-019-0040-5","article-title":"Targeting metabolic dysregulation for fibrosis therapy","volume":"19","author":"Zhao","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtn.2025.102807_bib8","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nrd.2015.3","article-title":"Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies","volume":"15","author":"Musso","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtn.2025.102807_bib9","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.matbio.2018.04.006","article-title":"Liver fibrosis: Direct antifibrotic agents and targeted therapies","volume":"68\u201369","author":"Schuppan","year":"2018","journal-title":"Matrix Biol."},{"key":"10.1016\/j.omtn.2025.102807_bib10","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s40256-014-0069-0","article-title":"Serelaxin: a novel therapy for acute heart failure with a range of hemodynamic and non-hemodynamic actions","volume":"14","author":"D\u00edez","year":"2014","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"10.1016\/j.omtn.2025.102807_bib11","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.mce.2007.09.008","article-title":"Adenovirus-mediated delivery of relaxin reverses cardiac fibrosis","volume":"280","author":"Bathgate","year":"2008","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.omtn.2025.102807_bib12","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1210\/en.2008-0250","article-title":"Relaxin ameliorates fibrosis in experimental diabetic cardiomyopathy","volume":"149","author":"Samuel","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.omtn.2025.102807_bib13","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.3748\/wjg.v23.i22.3999","article-title":"Serelaxin increases the antifibrotic action of rosiglitazone in a model of hepatic fibrosis","volume":"23","author":"Bennett","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.omtn.2025.102807_bib14","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/bcp.12572","article-title":"Pharmacokinetics of serelaxin in patients with hepatic impairment: a single-dose, open-label, parallel group study","volume":"79","author":"Kobalava","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.omtn.2025.102807_bib15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.pharmthera.2018.02.004","article-title":"Serelaxin as a novel therapeutic opposing fibrosis and contraction in lung diseases","volume":"187","author":"Lam","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.omtn.2025.102807_bib16","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1210\/en.2008-1457","article-title":"Relaxin reverses airway remodeling and airway dysfunction in allergic airways disease","volume":"150","author":"Royce","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.omtn.2025.102807_bib17","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1096\/fj.14-254789","article-title":"Combination therapy of mesenchymal stem cells and serelaxin effectively attenuates renal fibrosis in obstructive nephropathy","volume":"29","author":"Huuskes","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.omtn.2025.102807_bib18","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1161\/01.HYP.0000171930.00697.2f","article-title":"Relaxin reverses cardiac and renal fibrosis in spontaneously hypertensive rats","volume":"46","author":"Lekgabe","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.omtn.2025.102807_bib19","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1210\/en.2006-0814","article-title":"Endogenous relaxin is a naturally occurring modulator of experimental renal tubulointerstitial fibrosis","volume":"148","author":"Hewitson","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.omtn.2025.102807_bib20","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.knee.2019.01.010","article-title":"Regulation of MMP and TIMP expression in synovial fibroblasts from knee osteoarthritis with flexion contracture using adenovirus-mediated relaxin gene therapy","volume":"26","author":"Ko","year":"2019","journal-title":"Knee"},{"key":"10.1016\/j.omtn.2025.102807_bib21","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.pupt.2005.01.003","article-title":"Recombinant human relaxin reduces hypoxic pulmonary hypertension in the rat","volume":"18","author":"Tozzi","year":"2005","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.omtn.2025.102807_bib22","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013465","article-title":"Human Relaxin-2 Fusion Protein Treatment Prevents and Reverses Isoproterenol-Induced Hypertrophy and Fibrosis in Mouse Heart","volume":"8","author":"Sun","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.omtn.2025.102807_bib23","article-title":"Cellular delivery of relaxin-2 mRNA as a potential treatment for kidney fibrosis","volume":"21","author":"Ding","year":"2023","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.omtn.2025.102807_bib24","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/bph.13656","article-title":"Synthetic non-peptide low molecular weight agonists of the relaxin receptor 1","volume":"174","author":"Agoulnik","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.omtn.2025.102807_bib25","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/s41565-020-00836-6","article-title":"Hepatic macrophages act as a central hub for relaxin-mediated alleviation of liver fibrosis","volume":"16","author":"Hu","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.omtn.2025.102807_bib26","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1038\/s41467-019-10893-8","article-title":"Relaxin gene delivery mitigates liver metastasis and synergizes with check point therapy","volume":"10","author":"Hu","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2025.102807_bib27","doi-asserted-by":"crossref","first-page":"7263","DOI":"10.1038\/s41467-024-51571-8","article-title":"RNA nanotherapeutics with fibrosis overexpression and retention for MASH treatment","volume":"15","author":"Shan","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2025.102807_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114884","article-title":"Relaxin as an anti-fibrotic treatment: Perspectives, challenges and future directions","volume":"197","author":"Samuel","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.omtn.2025.102807_bib29","doi-asserted-by":"crossref","first-page":"12183","DOI":"10.1073\/pnas.1900355116","article-title":"Intraarticular injection of relaxin-2 alleviates shoulder arthrofibrosis","volume":"116","author":"Blessing","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2025.102807_bib30","doi-asserted-by":"crossref","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.omtn.2025.102807_bib31","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.ymthe.2019.07.001","article-title":"Circular RNAs: A Novel Class of Functional RNA Molecules with a Therapeutic Perspective","volume":"27","author":"Santer","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2025.102807_bib32","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1038\/s41388-023-02780-w","article-title":"Going circular: history, present, and future of circRNAs in cancer","volume":"42","author":"Pisignano","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.omtn.2025.102807_bib33","doi-asserted-by":"crossref","first-page":"D236","DOI":"10.1093\/nar\/gkaa823","article-title":"TransCirc: an interactive database for translatable circular RNAs based on multi-omics evidence","volume":"49","author":"Huang","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2025.102807_bib34","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.fmre.2023.02.022","article-title":"mRNA therapeutics: New vaccination and beyond","volume":"3","author":"Wei","year":"2023","journal-title":"Fundam. Res."},{"key":"10.1016\/j.omtn.2025.102807_bib35","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.molcel.2025.01.012","article-title":"Degradation of circular RNA by the ribonuclease DIS3","volume":"85","author":"Tao","year":"2025","journal-title":"Mol. Cell"},{"key":"10.1016\/j.omtn.2025.102807_bib36","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41580-020-0243-y","article-title":"The expanding regulatory mechanisms and cellular functions of circular RNAs","volume":"21","author":"Chen","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.omtn.2025.102807_bib37","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1038\/s41587-023-02095-x","article-title":"Prime editing using CRISPR-Cas12a and circular RNAs in human cells","volume":"42","author":"Liang","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2025.102807_bib38","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/jmcb\/mjz091","article-title":"IRES-mediated cap-independent translation, a path leading to hidden proteome","volume":"11","author":"Yang","year":"2019","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.omtn.2025.102807_bib39","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/jmcb\/mjy026","article-title":"Diverse roles of regulatory non-coding RNAs","volume":"10","author":"Wang","year":"2018","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.omtn.2025.102807_bib40","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1038\/s41467-022-31327-y","article-title":"Pervasive translation of circular RNAs driven by short IRES-like elements","volume":"13","author":"Fan","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2025.102807_bib41","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/cr.2017.31","article-title":"Extensive translation of circular RNAs driven by N(6)-methyladenosine","volume":"27","author":"Yang","year":"2017","journal-title":"Cell Res."},{"key":"10.1016\/j.omtn.2025.102807_bib42","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.ymthe.2024.04.028","article-title":"Circular RNA vaccines against monkeypox virus provide potent protection against vaccinia virus infection in mice","volume":"32","author":"Zhou","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2025.102807_bib43","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.omtn.2021.03.008","article-title":"Functionalized lipid nanoparticles for subcutaneous administration of mRNA to achieve systemic exposures of a therapeutic protein","volume":"24","author":"Davies","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2025.102807_bib44","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1038\/s41591-021-01583-4","article-title":"BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar","volume":"27","author":"Tang","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2025.102807_bib45","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1038\/s41467-024-47905-1","article-title":"Safety, immunogenicity and efficacy of the self-amplifying mRNA ARCT-154 COVID-19 vaccine: pooled phase 1, 2, 3a and 3b randomized, controlled trials","volume":"15","author":"H\u1ed3","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2025.102807_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114416","article-title":"The role of lipid components in lipid nanoparticles for vaccines and gene therapy","volume":"188","author":"Hald Albertsen","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.omtn.2025.102807_bib47","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.omtn.2025.102807_bib48","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/s41565-023-01453-9","article-title":"Close the cancer-immunity cycle by integrating lipid nanoparticle-mRNA formulations and dendritic cell therapy","volume":"18","author":"Zhang","year":"2023","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.omtn.2025.102807_bib49","article-title":"Harnessing the Loop: The Perspective of Circular RNA in Modern Therapeutics","volume":"13","author":"Zhao","year":"2025","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.omtn.2025.102807_bib50","doi-asserted-by":"crossref","first-page":"8480","DOI":"10.1038\/s41467-025-63343-z","article-title":"Circular RNA-based protein replacement therapy mitigates osteoarthritis in male mice","volume":"16","author":"Suo","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2025.102807_bib51","article-title":"A flexible, efficient, and scalable platform to produce circular RNAs as new therapeutics","author":"Chen","year":"2022","journal-title":"bioRxiv"},{"key":"10.1016\/j.omtn.2025.102807_bib52","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/cdd.2015.145","article-title":"Cleavage of DAP5 by coxsackievirus B3 2A protease facilitates viral replication and enhances apoptosis by altering translation of IRES-containing genes","volume":"23","author":"Hanson","year":"2016","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.omtn.2025.102807_bib53","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/15376516.2023.2244061","article-title":"Serum \u03b1-SMA is a potential noninvasive biomarker of liver fibrosis","volume":"34","author":"Cardoso-Lezama","year":"2024","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.omtn.2025.102807_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics10100784","article-title":"Liver Biopsy Hydroxyproline Content Is a Diagnostic for Hepatocellular Carcinoma in Murine Models of Nonalcoholic Steatohepatitis","volume":"10","author":"Bissoondial","year":"2020","journal-title":"Diagnostics"},{"key":"10.1016\/j.omtn.2025.102807_bib55","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1124\/mol.106.028951","article-title":"cAMP Inhibits Transforming Growth Factor-\u03b2-Stimulated Collagen Synthesis via Inhibition of Extracellular Signal-Regulated Kinase 1\/2 and Smad Signaling in Cardiac Fibroblasts","volume":"70","author":"Liu","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.omtn.2025.102807_bib56","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.molcel.2019.02.015","article-title":"RNA Circularization Diminishes Immunogenicity and Can Extend Translation Duration In Vivo","volume":"74","author":"Wesselhoeft","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.omtn.2025.102807_bib57","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.omtn.2022.04.017","article-title":"What goes around comes around: Artificial circular RNAs bypass cellular antiviral responses","volume":"28","author":"Breuer","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2025.102807_bib58","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1038\/s41467-018-05096-6","article-title":"Engineering circular RNA for potent and stable translation in eukaryotic cells","volume":"9","author":"Wesselhoeft","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2025.102807_bib59","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1038\/s41467-022-28776-w","article-title":"Combinatorial optimization of mRNA structure, stability, and translation for RNA-based therapeutics","volume":"13","author":"Leppek","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2025.102807_bib60","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/978-1-0716-4290-0_5","article-title":"A Review on Circular RNA Translation and Its Implications in Disease","volume":"2883","author":"Wei","year":"2025","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtn.2025.102807_bib61","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","article-title":"Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA","volume":"23","author":"Karik\u00f3","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.omtn.2025.102807_bib62","doi-asserted-by":"crossref","DOI":"10.1126\/science.ads4539","article-title":"Exogenous RNA surveillance by proton-sensing TRIM25","volume":"388","author":"Kim","year":"2025","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.omtn.2025.102807_bib63","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41586-023-06800-3","article-title":"N(1)-methylpseudouridylation of mRNA causes +1 ribosomal frameshifting","volume":"625","author":"Mulroney","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2025.102807_bib64","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/s41551-024-01306-3","article-title":"Efficient circular RNA synthesis for potent rolling circle translation","volume":"9","author":"Du","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.omtn.2025.102807_bib65","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/s41587-024-02393-y","article-title":"Chemical and topological design of multicapped mRNA and capped circular RNA to augment translation","volume":"43","author":"Chen","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2025.102807_bib66","doi-asserted-by":"crossref","first-page":"6455","DOI":"10.1038\/s41467-025-61775-1","article-title":"Chemical circularization of in vitro transcribed RNA for exploring circular mRNA design","volume":"16","author":"Wasinska-Kalwa","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2025.102807_bib67","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.molcel.2019.07.016","article-title":"N6-Methyladenosine Modification Controls Circular RNA Immunity","volume":"76","author":"Chen","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.omtn.2025.102807_bib68","article-title":"Mitigating Cellular Dysfunction Through Contaminant Reduction in Synthetic circRNA for High-Efficiency mRNA-Based Cell Reprogramming","volume":"12","author":"Zhang","year":"2025","journal-title":"Adv. Sci."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253125003610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253125003610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T01:13:27Z","timestamp":1780103607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253125003610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2162253125003610"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2025.102807","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circular RNA encoding relaxin-2 as a potential therapy for liver fibrosis","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2025.102807","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102807"}}